| 中国 | トルコ | オーストリア | |
| 自閉症治療 | から $4,800 | から $2,000 | から $5,000 |
| 成人統合失調症治療 | から $8,500 | から $2,000 | から $8,000 |
| 心理療法 | から $300 | から $150 | から $1,500 |
| 小児および青年の統合失調症治療 | から $8,800 | から $3,200 | から $10,000 |
| アルコール依存症治療 | から $5,800 | から $2,500 | から $6,000 |
Bookimedは精神科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。精神科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。精神科治療の旅路でお一人になることはありません。
Dr. Wang Lin is the Director of the Sleep Medicine Center at Xiamen Humanity Hospital. He leads a prominent collaborative clinical project with McLean Hospital, Harvard Medical School. Dr. Wang previously served as Associate Chief Physician of Psychiatry at Beijing Anding Hospital. He focuses on neuromodulation therapies for complex mental health conditions.
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).